View in EDS HTML Full Text PDF Full Text

Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.

Saved in:
Bibliographic Details
Title: Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.
Authors: Narikawa Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan., Kuramasu A; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan., Hosonuma M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Murayama M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan., Funayama E; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa Medical University, Tokyo, Japan., Sasaki A; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Baba Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan., Toyoda H; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Orthopedic Surgery, School of Medicine, Showa Medical University, Tokyo, Japan., Isobe J; Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan., Tajima K; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan., Nakashima R; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan., Sasaki A; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Maruyama Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Yamazaki Y; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa Medical University School of Pharmacy, Tokyo, Japan., Shida M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan., Tsurui T; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Hirasawa Y; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Ariizumi H; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Ishiguro T; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Suzuki R; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Ohkuma R; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Kubota Y; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Sambe T; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan., Tsuji M; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Wada S; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Horiike A; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Tsunoda T; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Kobayashi S; Department of Otorhinolaryngology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan., Kobayashi H; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan., Oguchi T; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Shimane T; Head and Neck Oncology Center, Showa Medical University, Tokyo, Japan., Kiuchi Y; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Yoshimura K; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan. kyoshim1@med.showa-u.ac.jp.; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Aug 19; Vol. 74 (9), pp. 289. Date of Electronic Publication: 2025 Aug 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40828195
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Narikawa+Y%22">Narikawa Y</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kuramasu+A%22">Kuramasu A</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.<br /><searchLink fieldCode="AU" term="%22Hosonuma+M%22">Hosonuma M</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Murayama+M%22">Murayama M</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Funayama+E%22">Funayama E</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+A%22">Sasaki A</searchLink>; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Baba+Y%22">Baba Y</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.<br /><searchLink fieldCode="AU" term="%22Toyoda+H%22">Toyoda H</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Orthopedic Surgery, School of Medicine, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Isobe+J%22">Isobe J</searchLink>; Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tajima+K%22">Tajima K</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.<br /><searchLink fieldCode="AU" term="%22Nakashima+R%22">Nakashima R</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+A%22">Sasaki A</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Maruyama+Y%22">Maruyama Y</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamazaki+Y%22">Yamazaki Y</searchLink>; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa Medical University School of Pharmacy, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shida+M%22">Shida M</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.<br /><searchLink fieldCode="AU" term="%22Tsurui+T%22">Tsurui T</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan.; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirasawa+Y%22">Hirasawa Y</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ariizumi+H%22">Ariizumi H</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ishiguro+T%22">Ishiguro T</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+R%22">Suzuki R</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohkuma+R%22">Ohkuma R</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kubota+Y%22">Kubota Y</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sambe+T%22">Sambe T</searchLink>; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuji+M%22">Tsuji M</searchLink>; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Wada+S%22">Wada S</searchLink>; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Horiike+A%22">Horiike A</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kobayashi+S%22">Kobayashi S</searchLink>; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsunoda+T%22">Tsunoda T</searchLink>; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kobayashi+S%22">Kobayashi S</searchLink>; Department of Otorhinolaryngology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Kobayashi+H%22">Kobayashi H</searchLink>; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Oguchi+T%22">Oguchi T</searchLink>; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shimane+T%22">Shimane T</searchLink>; Head and Neck Oncology Center, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kiuchi+Y%22">Kiuchi Y</searchLink>; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimura+K%22">Yoshimura K</searchLink>; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, 157-8577, Japan. kyoshim1@med.showa-u.ac.jp.; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan. kyoshim1@med.showa-u.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2025 Aug 19; Vol. 74 (9), pp. 289. <i>Date of Electronic Publication: </i>2025 Aug 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40828195
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-025-04111-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 289
    Titles:
      – TitleFull: Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Narikawa Y
      – PersonEntity:
          Name:
            NameFull: Kuramasu A
      – PersonEntity:
          Name:
            NameFull: Hosonuma M
      – PersonEntity:
          Name:
            NameFull: Murayama M
      – PersonEntity:
          Name:
            NameFull: Funayama E
      – PersonEntity:
          Name:
            NameFull: Sasaki A
      – PersonEntity:
          Name:
            NameFull: Baba Y
      – PersonEntity:
          Name:
            NameFull: Toyoda H
      – PersonEntity:
          Name:
            NameFull: Isobe J
      – PersonEntity:
          Name:
            NameFull: Tajima K
      – PersonEntity:
          Name:
            NameFull: Nakashima R
      – PersonEntity:
          Name:
            NameFull: Sasaki A
      – PersonEntity:
          Name:
            NameFull: Maruyama Y
      – PersonEntity:
          Name:
            NameFull: Yamazaki Y
      – PersonEntity:
          Name:
            NameFull: Shida M
      – PersonEntity:
          Name:
            NameFull: Tsurui T
      – PersonEntity:
          Name:
            NameFull: Hirasawa Y
      – PersonEntity:
          Name:
            NameFull: Ariizumi H
      – PersonEntity:
          Name:
            NameFull: Ishiguro T
      – PersonEntity:
          Name:
            NameFull: Suzuki R
      – PersonEntity:
          Name:
            NameFull: Ohkuma R
      – PersonEntity:
          Name:
            NameFull: Kubota Y
      – PersonEntity:
          Name:
            NameFull: Sambe T
      – PersonEntity:
          Name:
            NameFull: Tsuji M
      – PersonEntity:
          Name:
            NameFull: Wada S
      – PersonEntity:
          Name:
            NameFull: Horiike A
      – PersonEntity:
          Name:
            NameFull: Kobayashi S
      – PersonEntity:
          Name:
            NameFull: Tsunoda T
      – PersonEntity:
          Name:
            NameFull: Kobayashi S
      – PersonEntity:
          Name:
            NameFull: Kobayashi H
      – PersonEntity:
          Name:
            NameFull: Oguchi T
      – PersonEntity:
          Name:
            NameFull: Shimane T
      – PersonEntity:
          Name:
            NameFull: Kiuchi Y
      – PersonEntity:
          Name:
            NameFull: Yoshimura K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 08
              Text: 2025 Aug 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1